Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 31018-31019 [2012-12675]

Download as PDF 31018 Federal Register / Vol. 77, No. 101 / Thursday, May 24, 2012 / Notices required to complete the criminal history background checks mandated in the Crime Control Act of 1990, Public Law 101–647, dated November 29, 1990, as amended by Public Law 102–190, dated December 5, 1991. These statutes require that each employee of a child care center located in a Federal building or in leased space must undergo a background check. According to GSA policy, child care workers (as described above) will need to submit the following: 1. An original signed copy of a Basic National Agency Check Criminal History, GSA Form 176; and 2. Two sets of fingerprints on FBI Fingerprint Cards, for FD–258. This is not a request to collect new information, this is a request to change the form that is currently being used to collect this information. The new GSA forms will be less of a public burden. This information is presently being collected on either the old Federal Protective Service 176 Form or the SF85P. Please Note: The original request to review and approve the new information collection requirement regarding the collection of personal data for background check investigations was for both temporary contractors and child care workers accessing GSA owned and leased controlled facilities. However, through discussions with OMB a more streamlined will be developed for conducting background checks on temporary contractors. GSA is therefore pulling the request for review and approval of the collection of personal data for background check investigations of temporary contractors, form GSA 176T, presented in the Federal Register publication of February 17, 2009, 74 FR 7439. GSA is proceeding with the request for review and approval for background check investigations of child care workers, form GSA 176C—to be referred to as form GSA 176, HSPD–12, Background Check Investigations for Child Care Workers. srobinson on DSK4SPTVN1PROD with NOTICES B. Annual Reporting Burden Respondents: 3,060. Responses per Respondent: 1. Hours per Response: 1. Total Burden Hours: 3,060. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (MVCB), 1275 First Street NE., Washington, DC 20417, telephone (202) 501–4755. Please cite Background Investigations for Child Care Workers, in all correspondence. Dated: May 14, 2012. Casey Coleman, Chief Information Officer. [FR Doc. 2012–12645 Filed 5–23–12; 8:45 am] BILLING CODE 6820–23–P VerDate Mar<15>2010 16:31 May 23, 2012 Jkt 226001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors (BSC), National Center for Injury Prevention and Control (NCIPC) The meeting announced below concerns Research Grants for Preventing Violence and Violence Related Injury (R01), Funding Opportunity Announcements (FOA) CE12–002, and Identifying Modifiable Protective Factors for Intimate Partner Violence or Sexual Violence Perpetration (R01), FOA CE12–003. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–12:15 p.m., June 13, 2012 (Closed). 12:15 p.m.–1:00 p.m., June 13, 2012 (Open). Place: Teleconference. Status: A portion of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: Closed Session: The meeting will include the secondary review, discussion of competitive applications following initial review of applications received in response to FOA CE12–002; Research Grants for Preventing Violence and Violence Related Injury (R01) and CE12–003; and Identifying Modifiable Protective Factors for Intimate Partner Violence or Sexual Violence Perpetration (R01). Open Session: The meeting will include a science update, and a discussion on the pediatric traumatic brain injury workgroup. Contact Person for More Information: Gwendolyn Haile Cattledge, Ph.D., M.S.E.H., F.A.C.E., Deputy Associate Director for Science, CDC, 4770 Buford Highway, Atlanta, Georgia 30341, Telephone: (404) 488–1430. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 Dated: May 18, 2012. John Kastenbauer, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2012–12661 Filed 5–23–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Member Conflict Review, Program Announcement (PA) 07–318, and Centers of Excellence to Promote a Healthier Workforce Supplement, Request for Applications (RFA) OH 11– 001 initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–3:00 p.m., June 28, 2012 (Closed). Place: National Institute for Occupational Safety and Health (NIOSH), CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–6143. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Member Conflict Review, PA 07–318’’ and ‘‘Centers of Excellence to Promote a Healthier Workforce Supplement, RFA OH 11–001.’’ Contact Person for More Information: Bernadine Kuchinski, Ph.D., Scientific Review Administrator, Office of Extramural Programs, NIOSH, CDC, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–7, Cincinnati, Ohio 45226, Telephone: (513) 533–8511. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\24MYN1.SGM 24MYN1 31019 Federal Register / Vol. 77, No. 101 / Thursday, May 24, 2012 / Notices Dated: May 17, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2012–12675 Filed 5–23–12; 8:45 am] Proposed Information Collection Activity; Comment Request BILLING CODE 4163–18–P Administration for Children and Families Proposed Projects Title: FPLS Child Support Services Portal Registration (FCSSP). OMB No.: 0970–0370. Description: The purpose of the Federal Child Support Services Portal Registration is to collect information from an authorized individual registering to use the FPLS Child Support Services Portal. This information collection is necessary to authenticate the individual’s identity and comply with the statutory requirement that OCSE establish and implement safeguards to restrict access to confidential information in the FPLS to authorized persons. 42 U.S.C. 653(m)(2). After identity is authenticated, secure accounts will be created for authorized users to view data for their respective applications. Respondents: Employers, Financial Institutions, Insurers, State Agencies, Local Access and Visitation Providers. ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Registration Screens ....................................................................................... srobinson on DSK4SPTVN1PROD with NOTICES Instrument 588 1 0.10 58.8 Estimated Total Annual Burden Hours: 58.8. In compliance with the requirements of Section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to VerDate Mar<15>2010 16:31 May 23, 2012 Jkt 226001 comments and suggestions submitted within 60 days of this publication. Robert Sargis, Reports Clearance Officer. [FR Doc. 2012–12601 Filed 5–23–12; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2012–N–1029] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by June 25, 2012. SUMMARY: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, Fax: 202– ADDRESSES: PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 395–7285, or emailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–New and title ‘‘General Licensing Provisions; Section 351(k) Biosimilar Applications’’. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50–400B, Rockville, MD 20850, 301–796–7651, juanmanuel.vilela@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. General Licensing Provisions; Section 351(k) Biosimilar Applications—(OMB Control Number 0910—New) On March 23, 2010, the President signed into law the Patient Protection and Affordable Care Act (Affordable Care Act) (Pub. L. 111–148). The Affordable Care Act contains a subtitle called the Biologics Price Competition and Innovation Act of 2009 (BPCI Act) which amends the Public Health Service Act (PHS Act) and establishes an abbreviated licensure pathway for biological products shown to be biosimilar to, or interchangeable with, an FDA-licensed biological reference product. (See sections 7001 through 7003 of the Affordable Care Act.) Section 351(k) of the PHS Act (42 U.S.C. 262(k)), added by the BPCI Act, E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 77, Number 101 (Thursday, May 24, 2012)]
[Notices]
[Pages 31018-31019]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12675]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Member Conflict Review, 
Program Announcement (PA) 07-318, and Centers of Excellence to Promote 
a Healthier Workforce Supplement, Request for Applications (RFA) OH 11-
001 initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 1:00 p.m.-3:00 p.m., June 28, 2012 (Closed).
    Place: National Institute for Occupational Safety and Health 
(NIOSH), CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506, 
Telephone: (304) 285-6143.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Member Conflict Review, PA 07-318'' and ``Centers of Excellence to 
Promote a Healthier Workforce Supplement, RFA OH 11-001.''
    Contact Person for More Information: Bernadine Kuchinski, Ph.D., 
Scientific Review Administrator, Office of Extramural Programs, NIOSH, 
CDC, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C-7, 
Cincinnati, Ohio 45226, Telephone: (513) 533-8511.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.


[[Page 31019]]


    Dated: May 17, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-12675 Filed 5-23-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.